Post-Market Surveillance Overview
Obligations Do Not End at Approval
Obtaining a NIE is not the end of the regulatory journey — it is the beginning of an ongoing compliance relationship with Kemenkes. Both the foreign manufacturer and the Indonesian LAR have continuing post-market obligations that must be actively managed.
Core PMS Obligations
| Obligation | Who | Frequency |
|---|---|---|
| Adverse event reporting | LAR (on behalf of manufacturer) | As events occur — serious incidents promptly |
| Periodic safety updates | Manufacturer + LAR | As directed by Kemenkes; Class D: regular PSURs |
| Device traceability | LAR | Ongoing; critical for Class C/D |
| Recall readiness and plan | LAR | Documented plan required; activated when needed |
| NIE renewal | LAR | Before 5-year expiry |
| Change notifications | LAR | When device or labeling changes occur |
| CDAKB compliance | LAR | Ongoing; subject to Kemenkes inspection |
| Label compliance | Manufacturer + LAR | Ongoing; Kemenkes conducts market sampling |
Kemenkes Market Sampling
Kemenkes conducts regular market sampling — purchasing products from hospitals and pharmacies across Indonesia and comparing them against the approved label in Regalkes. This serves as a real-world check on label compliance, including:
- Correct NIE number on packaging
- Bahasa Indonesia content present and correct
- Label matches the Regalkes-approved version
- Halal labeling compliance as deadlines pass
Sanctions Regime
Kemenkes operates a tiered sanctions system for non-compliance:
| Level | Sanction | Typical Trigger |
|---|---|---|
| Level 1 | Written warning (surat peringatan) | Minor labeling or documentation non-compliance identified in market sampling |
| Level 2 | NIE suspension | Failure to remedy Level 1 warning; LAR's CDAKB suspended; serious safety concern |
| Level 3 | NIE revocation + mandatory recall | Serious safety risk; persistent non-compliance; fraud; unresolved Level 2 |
A Level 3 revocation with mandatory recall requires the NIE holder to fund and execute the retrieval of all affected products from every hospital and pharmacy in Indonesia — a potentially enormous cost and reputational consequence.
Shared Responsibility
Under the LAR structure, there is a shared responsibility for PMS:
- The LAR is the legally accountable party in Indonesia
- The manufacturer retains technical responsibility for global safety data, FSCA decisions, and product quality
- Effective communication between manufacturer and LAR is essential — a poorly designed communication protocol is the most common source of PMS failures